Characterization of a Salmonella enterica serovar Agona strain harbouring a class 1 integron containing novel OXA-type beta-lactamase (blaOXA-53) and 6'-N-aminoglycoside acetyltransferase genes [aac(6')-I30

The Journal of Antimicrobial Chemotherapy
Michael R MulveyLai-King Ng

Abstract

To characterize by molecular methods a multidrug-resistant Salmonella enterica serovar Agona (S. enterica Agona) isolated from a hospitalized patient in Rio de Janeiro, Brazil. The S. enterica Agona strain was screened by PCR and DNA sequencing for TEM, SHV and CTX-M-type beta-lactamase genes, tet(A), (B), (C) and (D) tetracycline resistance genes, chloramphenicol resistance genes and class 1 integrons. Plasmid characterization was carried out by PCR and Southern hybridization analysis. PCR and PFGE were used to characterize nine other S. enterica Agona strains collected from hospitals in Rio de Janeiro. The study strain was found to harbour a 105 kb plasmid, which contained catA1, bla(TEM-1), a class 1 integron with two novel genes labelled bla(OXA-53) and aac(6')-I30, respectively, and an additional unidentified aminoglycoside resistance gene. A second 53 kb plasmid from the same strain contained tet(D) and bla(SHV-5). OXA-53 was shown to provide reduced susceptibility to ceftazidime, and its activity was inhibited in the presence of clavulanic acid. PFGE analysis of the nine other S. enterica Agona strains revealed two clusters of related strains (78% similarity), and PCR analysis showed that all strains contained the novel ...Continue Reading

Citations

Oct 24, 2007·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Aphrodite DourisCharlene R Jackson
Oct 28, 2009·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Sueli A FernandesYohei Doi
Oct 17, 2012·Antimicrobial Agents and Chemotherapy·Tatsuya TadaTeruo Kirikae
Sep 2, 2009·Antimicrobial Agents and Chemotherapy·Laurent PoirelPatrice Nordmann
Mar 23, 2011·Antimicrobial Agents and Chemotherapy·Sally R PartridgeJonathan R Iredell
Jun 19, 2008·Antimicrobial Agents and Chemotherapy·Christopher R BethelRobert A Bonomo
Jan 13, 2010·Clinical Microbiology Reviews·Sarah M Drawz, Robert A Bonomo
Jan 29, 2014·Antimicrobial Agents and Chemotherapy·Nuno T AntunesSergei B Vakulenko
Aug 20, 2014·Antimicrobial Agents and Chemotherapy·Nicolás F CordeiroRafael Vignoli
Mar 29, 2011·Critical Reviews in Microbiology·Chedly ChouchaniAllaaeddin El Salabi
Jul 20, 2011·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Felisa A Smith, S Kathleen Lyons
Mar 12, 2005·The Journal of Antimicrobial Chemotherapy·Geovana Brenner MichaelStefan Schwarz
Jan 1, 2014·Antibiotics·Nuno T Antunes, Jed F Fisher
Mar 29, 2007·Journal of Food Protection·Samuel D AlcaineMartin Wiedmann
Jan 1, 2021·The Journal of Antimicrobial Chemotherapy·Eun-Jeong Yoon, Seok Hoon Jeong
May 24, 2006·Microbes and Infection·Geovana Brenner MichaelStefan Schwarz
Sep 14, 2010·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Maria S Ramirez, Marcelo E Tolmasky

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.